Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Eli Lilly Reveals Plans for a $2.5 Billion Investment to Expand Injectable Manufacturing Capacity in Germany
Eli Lilly and Company plans to build a hightech manufacturing facility in Alzey, Rhineland Palatinate, Germany
Aragen Unveils Groundbreaking $30 Million Investment for Bio-Manufacturing Facility in India
Aragen, a leading CRDMO specializing in small molecules and biologics, is establishing a new biologics manufacturing facility in Bangalore, India
Bayer Invests $250 Million in First Global Cell Therapy Manufacturing Facility for Regenerative Medicines
The facility aims to produce cell and gene therapies on a global scale, making them more accessible worldwide
Sandoz Invests $90 Million in Advanced Biosimilar Technical Development CenterIntroduction
Sandozs investment sets the stage for a significant transformation of the Ljubljana site into a central hub for advancing biosimilar products within the company
Novo Nordisk Foundation Invests EUR 127 Million in Advancing Human Cell Therapy Scaling
The Novo Nordisk Foundation is embarking on a groundbreaking journey, dedicating its resources to forge a stateoftheart facility that will serve as the ultimate crucible
McCord Development Invests $30M in Biohub Two at Houston's Life Science Ecosystem
McCord Development is strengthening its presence in the life sciences and biomanufacturing sector with the launch of BioHub Two
ST Pharm Invests US$110 million to Open New Oligonucleotide Facility in South Korea
ST Pharm invests US$110 million to open new stateoftheart Oligonucleotide facility at Banwol campus, South Korea
Sandoz Unveils $90M Investment in Slovenian Biosimilar Development Center
Sandozs investment sets the stage for a significant transformation of the Ljubljana site into a central hub for advancing biosimilar products within the company
Biovian announces €50 Million Investment in State-of-the-Art Manufacturing Hub in Finland
Prominent contract development and manufacturing organization CDMO, Biovian Oy, known for its expertise in biopharmaceuticals, announces a significant upgrade to its Turku manufacturing facility
MilliporeSigma to Invest $25 Million in Expanding Cell Culture Media Production in Kansas
The expansion will involve the addition of 98,000 square feet of lab space and production capability specifically for manufacturing cell culture media
